Antimony Oxide Sb2O3
SAFETY DATA SHEET
1 PRODUCT AND SUPPLIER IDENTIFICATION
Product Name: Antimony Oxide
Formula: Sb2O3
Supplier: ESPI Metals
1050 Benson Way
Ashland, OR 97520
Telephone: 800-638-2581
Fax: 541-488-8313
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Emergency: Infotrac 800-535-5053 (US) or 352-323-3500 (24 hour)
Recommended Uses: Scientific Research
2 HAZARDS IDENTIFICATION
GHS Classification (29 CFR 1910.1200): Carcinogenicity, category 2.
GHS Label Elements:
Signal Word: Warning
Hazard Statements: H351 Suspected of causing cancer.
Precautionary Statements: P201 Obtain special instructions before use, P202 Do not handle until all safety precautions have been read and understood, P280 Wear protective gloves/protective clothing/eye protection/face protection, P308+P313 IF exposed or concerned: Get medical advice/attention, P405 Store locked up, P501 Dispose of contents/container in accordance with local, state or federal regulations.
3 COMPOSITION/INFORMATION ON INGREDIENTS
Ingredient: Antimony (III) Oxide
CAS#: 1309-64-4
%: 100
EC#: 215-175-0
Common Names and Synonyms: Antimony trioxide.
4 FIRST AID MEASURES
General Measures: Remove patient from area of exposure.
INHALATION: Remove to fresh air, keep warm and quiet, give oxygen if breathing is difficult. Seek medical attention.
INGESTION: Rinse mouth with water. Do not induce vomiting. Seek medical attention. Never induce vomiting or give anything by mouth to an unconscious person.
SKIN: Remove contaminated clothing, brush material off skin, wash affected area with soap and water. Seek medical attention if irritation develops or persists.
EYES: Flush eyes with lukewarm water, including under upper and lower eyelids, for at least 15 minutes. Seek medical attention if irritation develops or persists.
Most Important Symptoms/Effects, Acute and Delayed: May cause irritation. See section 11 for more information.
Indication of Immediate Medical Attention and Special Treatment: No other relevant information available.
5 FIREFIGHTING MEASURES
Extinguishing Media: Use suitable extinguishing agent for surrounding materials and type of fire.
Unsuitable Extinguishing Media: No information available.
Specific Hazards Arising from the Material: May release antimony oxide fume if involved in a fire.
Special Protective Equipment and Precautions for Firefighters: Wear full face, self-contained breathing apparatus and full protective clothing.
6 ACCIDENTAL RELEASE MEASURES
Personal Precautions, Protective Equipment, and Emergency Procedures: Wear appropriate respiratory and protective equipment specified in section 8. Isolate spill area and provide ventilation. Avoid breathing dust or fume. Avoid contact with skin and eyes. Eliminate all sources of ignition.
Methods and Materials for Containment and Cleaning Up: Avoid raising dust. Scoop or vacuum up using a vacuum system equipped with a HEPA filter. Place in properly labeled closed containers.
Environmental Precautions: Do not allow to enter drains or to be released to the environment.
7 HANDLING AND STORAGE
Precautions for Safe Handling: Handle in an enclosed, controlled process. Avoid creating dust. Avoid breathing dust or fumes. Provide adequate ventilation if dusts are created. Avoid contact with skin and eyes. Wash thoroughly before eating or smoking. See section 8 for information on personal protection equipment.
Conditions for Safe Storage: Store in a cool, dry area. Store material tightly sealed in properly labeled containers. Protect from moisture. Do not store together with oxidizers. See section 10 for more information on incompatible materials.
8 EXPOSURE CONTROLS AND PERSONAL PROTECTION
Exposure Limits: OSHA/PEL: ACGIH/TLV:
Antimony (III) Oxide No exposure limit established No exposure limit established
Antimony and compounds (as Sb) 0.5 mg/m3 0.5 mg/m3
Engineering Controls: Handle in a controlled, enclosed environment. Whenever possible the use of local exhaust ventilation or other engineering controls is the preferred method of controlling exposure to airborne dust and fume to meet established occupational exposure limits. Use good housekeeping and sanitation practices. Do not use tobacco or food in work area. Wash thoroughly before eating or smoking. Do not blow dust off clothing or skin with compressed air.
Individual Protection Measures, Such as Personal Protective Equipment:
Respiratory Protection: Use suitable respirator when high concentrations are present.
Eye Protection: Safety glasses
Skin Protection: Impermeable gloves, protective work clothing as necessary.
9 PHYSICAL AND CHEMICAL PROPERTIES
Appearance:
Form: Powder or pieces
Color: White
Odor: Odorless
Odor Threshold: Not determined
pH: N/A
Melting Point: 656 oC
Boiling Point: 1550 oC (sublimes)
Flash Point: N/A
Evaporation Rate: N/A
Flammability: No data
Upper Flammable Limit: No data
Lower Flammable Limit: No data
Vapor Pressure: 1 mm Hg @ 574 oC
Vapor Density: N/A
Relative Density (Specific Gravity): 5.2 g/cc
Solubility in H2O: Very slightly soluble in cold water
Partition Coefficient (n-octanol/water): Not determined
Autoignition Temperature: No data
Decomposition Temperature: No data
Viscosity: N/A
10 STABILITY AND REACTIVITY
Reactivity: No specific test data available.
Chemical Stability: Stable under recommended storage conditions.
Possibility of Hazardous Reactions: Hazardous polymerization will not occur.
Conditions to Avoid: No data
Incompatible Materials: Strong oxidizing agents.
Hazardous Decomposition Products: Antimony oxide fume.
11 TOXICOLOGICAL INFORMATION
Likely Routes of Exposure: Inhalation, skin and eyes.
Symptoms of Exposure: May cause irritation and possibly systemic effects including a metallic taste in the mouth, vomiting, colic, loss of appetite and weight, and diarrhea.
Acute and Chronic Effects:
Antimony Compounds: Fatalities from antimony poisoning are rare. Acute systemic exposure to antimony compounds may cause loss of hair, dry scaly skin, and weight loss. Damage to the heart, liver, and kidneys can occur, and death from myocardial failure may follow.
Acute Toxicity: LD50 oral - rat - >20,000 mg/kg
Carcinogenicity: NTP: Not identified as carcinogenic IARC: 2B - Possibly carcinogenic to humans
To the best of our knowledge the chemical, physical and toxicological characteristics of the substance are not fully known.
12 ECOLOGICAL INFORMATION
Ecotoxicity: No data
Persistence and Degradability: No data
Bioaccumulative Potential: No data
Mobility in Soil: No data
Other Adverse Effects: Do not allow material to be released to the environment. No further relevant information available.
13 DISPOSAL CONSIDERATIONS
Waste Disposal Method:
Product: Dispose of in accordance with Federal, State and Local regulations.
Packaging: Dispose of in accordance with Federal, State and Local regulations.
14 TRANSPORT INFORMATION
UN Number: UN1549
UN Proper Shipping Name: Antimony compounds, inorganic, solid, n.o.s. (Antimony trioxide)
Transport Hazard Class: 6.1
Packing Group: III
Marine Pollutant: No
15 REGULATORY INFORMATION
TSCA Listed: Yes
DSL Listed: Yes
Regulation (EC) No 1272/2008 (CLP): Carcinogenicity, category 1B, Specific target organ toxicity - single exposure (respiratory), category 2.
WHMIS 2015 Classification: Carcinogenicity.
HMIS Ratings: Health: 2*(chronic) Flammability: 0 Physical: 0
NFPA Ratings: Health: 2 Flammability: 0 Instability: 0
Chemical Safety Assessment: A chemical safety assessment has not been carried out.
16 OTHER INFORMATION
The information contained in this document is based on the state of our knowledge at the time of publication and is believed to be correct, but does not purport to be all inclusive and shall be used only as a guide. ESPI Metals makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. ESPI Metals shall not be held liable for any damages resulting from handling or from contact with the above product. Users should satisfy themselves that they have all current data relevant to their particular use.
Prepared by: ESPI Metals
Revised/Reviewed: August 2016